View in EDS

4-O-Demethylbarbatic acid has a novel therapeutic impact on the progression of EGFR-driven lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: 4-O-Demethylbarbatic acid has a novel therapeutic impact on the progression of EGFR-driven lung adenocarcinoma.
Authors: Varlı M; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Sunchon, Jeonnam, 57922, Republic of Korea., Zhou R; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Sunchon, Jeonnam, 57922, Republic of Korea., Liu R; Korean Lichen Research Institute, Sunchon National University, 255 Jungang-ro, Sunchon, Jeonnam, 57922, Republic of Korea., Rho JK; Department of Convergence Medicine, University of Ulsan, College of Medicine, Seoul, 05505, Republic of Korea., Ha HH; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Sunchon, Jeonnam, 57922, Republic of Korea., Hur JS; Korean Lichen Research Institute, Sunchon National University, 255 Jungang-ro, Sunchon, Jeonnam, 57922, Republic of Korea., Kim H; College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungang-ro, Sunchon, Jeonnam, 57922, Republic of Korea. Electronic address: hangunkim@sunchon.ac.kr.
Source: Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2025 Sep; Vol. 145, pp. 156973. Date of Electronic Publication: 2025 Jun 11.
Publication Type: Journal Article
Journal Info: Publisher: Urban & Fischer Verlag Country of Publication: Germany NLM ID: 9438794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-095X (Electronic) Linking ISSN: 09447113 NLM ISO Abbreviation: Phytomedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1618-095X
DOI:10.1016/j.phymed.2025.156973